Coronary Stents Market to Cross US$ 12.8 Bn by 2035 Driven by Minimally Invasive Interventions and Technological Innovation: Transparency Market Research

The global coronary stents market was valued at US$ 7,222.5 Mn in 2024 and is projected to expand at a CAGR of 5.3% from 2025 to 2035, reaching US$ 12,846.6 Mn by 2035, according to a new market outlook by Transparency Market Research. Market growth is fueled by increasing prevalence of coronary artery disease (CAD), rising preference for minimally invasive procedures, and favorable reimbursement frameworks across key healthcare economies.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23

Analysts' Viewpoint

The coronary stents industry is undergoing transformative shifts, driven by continuous innovation in stent materials, design, and drug-delivery mechanisms. The increasing burden of cardiovascular diseases due to lifestyle disorders and aging populations globally underscores the critical role of stents in cardiac intervention.

The market is particularly benefiting from rapid adoption of drug-eluting stents (DES) and bioresorbable scaffolds, with key players investing in next-gen platforms that improve long-term outcomes and reduce restenosis.

Market Overview

Coronary stents are tiny mesh tubes used to treat blocked coronary arteries and restore blood flow to the heart. They are commonly deployed during angioplasty procedures and are crucial in managing coronary artery disease (CAD).

There are three main types:

Bare Metal Stents (BMS)
Drug-Eluting Stents (DES)
Bioabsorbable Vascular Scaffolds (BVS)

DES dominate the market owing to their superior performance in reducing restenosis and the need for repeat interventions. Innovations in cobalt-chromium and stainless steel materials, along with biodegradable polymers, have significantly improved stent efficacy and patient safety.

Key Market Drivers

Rising Demand for Minimally Invasive Procedures

Minimally invasive coronary interventions such as percutaneous coronary intervention (PCI) have become standard treatment protocols due to their quicker recovery times, reduced hospital stays, and improved patient outcomes. Technological advances in DES and BVS have enabled more complex procedures to be performed with lower complication rates.

Favorable Reimbursement Policies

Governments and healthcare payers are supporting the uptake of advanced cardiovascular devices through broad reimbursement schemes. Countries across North America, Europe, and Asia are adopting value-based reimbursement models, encouraging healthcare providers to use safer, more effective stents like DES and bioresorbable scaffolds.

This financial support makes coronary stent procedures more accessible and boosts adoption rates, especially in emerging healthcare markets.

Segment Insights

By Type

Drug-Eluting Stents (DES) dominate due to their proven ability to reduce restenosis and long-term complications. Innovations such as everolimus and sirolimus coatings are enhancing performance further.

Bare-Metal Stents (BMS) have declined in use but remain relevant in certain patient subsets.
Bioabsorbable Scaffolds (BVS) are emerging as the next wave of innovation, though adoption is still in early phases.
By Material

Metal-based stents, especially cobalt-chromium and stainless steel, offer optimal flexibility, visibility, and strength.

Polymer stents, including biodegradable polymers, are gaining attention for their long-term benefits and improved healing response.

By End-user

Hospitals and cardiac centers are the primary end-users, driven by the availability of trained interventional cardiologists and high procedural volumes.

Regional Outlook

North America leads the global coronary stents market with over 35% share in 2024, supported by:

High prevalence of CAD and aging population
Strong R&D infrastructure
Early adoption of next-gen stent technologies
Favorable reimbursement and regulatory pathways
Asia Pacific is projected to witness the fastest growth through 2035. Factors include:

Expanding healthcare infrastructure
Rising medical tourism in India, China, and Thailand
Government initiatives for non-communicable disease management

Key Companies and Competitive Landscape

Prominent players are focusing on regulatory approvals, new product launches, and strategic partnerships to strengthen their market presence.

Leading Players

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
B. Braun Melsungen AG
Terumo Corporation
Lepu Medical
Elixir Medical Corp.
Cook Medical Inc.
Biosensors International Group
MicroPort Scientific
Meril Life Sciences Pvt. Ltd.
Sino Medical Sciences Technology Inc.
AlviMedica
Eurocor GmbH
OrbusNeich Medical
Balton

These companies are actively expanding portfolios with innovative DES and scaffolds, improving procedural success rates and long-term patient care.

Recent Developments

October 2024 - Elixir Medical presented new data on DynamX Coronary Bioadaptor System, showing superior outcomes compared to traditional DES in complex patient populations.

May 2024 - Abbott launched XIENCE Sierra, an everolimus DES platform in India with improved deliverability and clinical performance in complex coronary cases.

Market Segmentation

By Type

Bare Metal Stent (BMS)
Drug Eluting Stent (DES)
Bioabsorbable Vascular Scaffold (BVS)

By Material

Metal
Polymer

By End-user

Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Buy this Premium Research Report:

https://www.transparencymarketresearch.com/checkout.php?rep_id=23<ype=S

Explore Latest Research Reports by Transparency Market Research:

Ostomy Drainage Bags Market- https://www.transparencymarketresearch.com/ostomy-drainage-bags-market.html

Assistive Technologies for Visually Impaired Market- https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html

Remote Patient Monitoring Devices Market- https://www.transparencymarketresearch.com/remote-patient-monitoring-devices-market.html

Wound Healing Market- https://www.transparencymarketresearch.com/wound-healing-market.html

Contraceptive Sponge Market- https://www.transparencymarketresearch.com/contraceptive-sponge-market.html

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.